CEACAM5 and neoplasm: Parameters for NSCLC surveillance, including preoperative biomarkers (serum carcinoembryonic antigen (CEA), serum cytokeratin 19 fragment (CYFRA 21-1)), tumor size, cell subtypes, and differentiation, are useful prognostic markers [12,13].